Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000630429 | SCV000751385 | pathogenic | Hereditary nonpolyposis colorectal neoplasms | 2022-10-24 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 1-6 of the MSH2 gene, which includes the initiator codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. However, if EPCAM has been tested and no copy number events are reported then the 5' boundary of this event lies between the EPCAM and MSH2 genes. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MSH2 are known to be pathogenic (PMID: 15849733, 24362816). A similar copy number variant has been observed in individual(s) with clinical features of Lynch syndrome (PMID: 9843200, 15713769, 15870828, 15942939, 16086322, 16142001, 16143124, 19930554, 20591884, 22283331, 25759555). It is commonly reported in individuals of American ancestry (PMID: 14871915, 16143124; SOURCE: 12658575). For these reasons, this variant has been classified as Pathogenic. |